FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

13771211000001102: Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49058201000001112 Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53201001000001118 Terbinafine 250mg tablets (Apotex UK Ltd) 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Is a Terbinafine 250mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Is pack of Terbinafine 250mg tablets (Apotex Europe Ltd) false Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has active ingredient Terbinafine hydrochloride false Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has AMP Terbinafine 250mg tablets (Apotex Europe Ltd) true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terbinafine true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has specific active ingredient Terbinafine hydrochloride true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Terbinafine 250mg tablets (Apotex Europe Ltd) 14 tablet Has basis of strength substance Terbinafine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start